201 related articles for article (PubMed ID: 10329606)
1. DNA copy number changes in thyroid carcinoma.
Hemmer S; Wasenius VM; Knuutila S; Franssila K; Joensuu H
Am J Pathol; 1999 May; 154(5):1539-47. PubMed ID: 10329606
[TBL] [Abstract][Full Text] [Related]
2. Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity.
Wreesmann VB; Ghossein RA; Hezel M; Banerjee D; Shaha AR; Tuttle RM; Shah JP; Rao PH; Singh B
Genes Chromosomes Cancer; 2004 Aug; 40(4):355-64. PubMed ID: 15188460
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial DNA alterations in thyroid cancer.
Tong BC; Ha PK; Dhir K; Xing M; Westra WH; Sidransky D; Califano JA
J Surg Oncol; 2003 Mar; 82(3):170-3. PubMed ID: 12619060
[TBL] [Abstract][Full Text] [Related]
4. Adenomas and follicular carcinomas of the thyroid display two major patterns of chromosomal changes.
Castro P; Eknaes M; Teixeira MR; Danielsen HE; Soares P; Lothe RA; Sobrinho-Simões M
J Pathol; 2005 Jul; 206(3):305-11. PubMed ID: 15852498
[TBL] [Abstract][Full Text] [Related]
5. Chromosome imbalances in thyroid follicular neoplasms: a comparison between follicular adenomas and carcinomas.
Roque L; Rodrigues R; Pinto A; Moura-Nunes V; Soares J
Genes Chromosomes Cancer; 2003 Mar; 36(3):292-302. PubMed ID: 12557229
[TBL] [Abstract][Full Text] [Related]
6. Genomic aberrations in carcinomas of the uterine corpus.
Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
[TBL] [Abstract][Full Text] [Related]
7. Contribution of p53 gene alterations to development of metastatic forms of follicular thyroid carcinoma.
Sápi Z; Lukács G; Sztán M; Papp J; Oláh E
Diagn Mol Pathol; 1995 Dec; 4(4):256-60. PubMed ID: 8634781
[TBL] [Abstract][Full Text] [Related]
8. Infrequent CDKN2 mutation in human differentiated thyroid cancers.
Tung WS; Shevlin DW; Bartsch D; Norton JA; Wells SA; Goodfellow PJ
Mol Carcinog; 1996 Jan; 15(1):5-10. PubMed ID: 8561866
[TBL] [Abstract][Full Text] [Related]
9. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
10. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events.
Gronwald J; Störkel S; Holtgreve-Grez H; Hadaczek P; Brinkschmidt C; Jauch A; Lubinski J; Cremer T
Cancer Res; 1997 Feb; 57(3):481-7. PubMed ID: 9012478
[TBL] [Abstract][Full Text] [Related]
11. Low frequency of numerical chromosomal aberrations in follicular thyroid tumors detected by comparative genomic hybridization.
Frisk T; Kytölä S; Wallin G; Zedenius J; Larsson C
Genes Chromosomes Cancer; 1999 Aug; 25(4):349-53. PubMed ID: 10398428
[TBL] [Abstract][Full Text] [Related]
12. The natural protein kinase C alpha mutant is present in human thyroid neoplasms.
Prévostel C; Alvaro V; de Boisvilliers F; Martin A; Jaffiol C; Joubert D
Oncogene; 1995 Aug; 11(4):669-74. PubMed ID: 7651730
[TBL] [Abstract][Full Text] [Related]
13. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.
Dahia PL; Marsh DJ; Zheng Z; Zedenius J; Komminoth P; Frisk T; Wallin G; Parsons R; Longy M; Larsson C; Eng C
Cancer Res; 1997 Nov; 57(21):4710-3. PubMed ID: 9354427
[TBL] [Abstract][Full Text] [Related]
14. [Loss of heterozygosity on chromosome 3p in thyroid tumors].
Hu MJ; Xu HD; Zhou R; Li XF; Zhang HY
Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):305-8. PubMed ID: 18956647
[TBL] [Abstract][Full Text] [Related]
15. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.
Obermann EC; Junker K; Stoehr R; Dietmaier W; Zaak D; Schubert J; Hofstaedter F; Knuechel R; Hartmann A
J Pathol; 2003 Jan; 199(1):50-7. PubMed ID: 12474226
[TBL] [Abstract][Full Text] [Related]
16. BRAF copy number gains in thyroid tumors detected by fluorescence in situ hybridization.
Ciampi R; Zhu Z; Nikiforov YE
Endocr Pathol; 2005; 16(2):99-105. PubMed ID: 16199894
[TBL] [Abstract][Full Text] [Related]
17. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays.
Zhao J; Leonard C; Brunner E; Gemsenjäger E; Heitz PU; Odermatt B
Int J Oncol; 2006 Nov; 29(5):1041-51. PubMed ID: 17016634
[TBL] [Abstract][Full Text] [Related]
19. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
20. Allelotyping of follicular thyroid carcinoma: frequent allelic losses in chromosome arms 7q, 11p, and 22q.
Kitamura Y; Shimizu K; Ito K; Tanaka S; Emi M
J Clin Endocrinol Metab; 2001 Sep; 86(9):4268-72. PubMed ID: 11549660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
